Prospera Financial Services Inc Zai Lab LTD Transaction History

Prospera Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $319,515 - $542,779	-3,043 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $27,399 - $39,420	219 Added 7.75%	3,043 $539,000
Q1 2021 May 06, 2021	BUY	$126.27 - $191.71 $90,156 - $136,880	714 Added 33.84%	2,824 $377,000
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $172,893 - $285,567	2,110 New	2,110 $286,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.